These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30623764)

  • 1. [Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy].
    Valéra MC; Fontaine C; Noirrit-Esclassan E; Boudou F; Buscato M; Adlanmerini M; Trémollières F; Gourdy P; Lenfant F; Arnal JF
    Med Sci (Paris); 2018 Dec; 34(12):1056-1062. PubMed ID: 30623764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards optimization of estrogen receptor modulation in medicine.
    Valéra MC; Fontaine C; Dupuis M; Noirrit-Esclassan E; Vinel A; Guillaume M; Gourdy P; Lenfant F; Arnal JF
    Pharmacol Ther; 2018 Sep; 189():123-129. PubMed ID: 29730442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].
    Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF
    Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a SERM in your menopause toolkit?
    Liu JH
    Menopause; 2017 Mar; 24(3):320-321. PubMed ID: 28098599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
    Serock MR; Wells AK; Khalil RA
    Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular effects of estrogenic menopausal hormone therapy.
    Reslan OM; Khalil RA
    Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of specific estrogen receptor modulators (SERMs).
    Ibrahim NK; Hortobagyi GN
    Surg Oncol; 1999 Aug; 8(2):103-23. PubMed ID: 10732962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.
    Guillaume M; Handgraaf S; Fabre A; Raymond-Letron I; Riant E; Montagner A; Vinel A; Buscato M; Smirnova N; Fontaine C; Guillou H; Arnal JF; Gourdy P
    Am J Pathol; 2017 Jun; 187(6):1273-1287. PubMed ID: 28502695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging hormonal treatments for menopausal symptoms.
    Genazzani AR; Komm BS; Pickar JH
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to menopausal therapy: the tissue selective estrogen complex.
    Komm BS
    Reprod Sci; 2008 Dec; 15(10):984-92. PubMed ID: 19088368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there still a role for SERMs in menopause management?
    Lello S; Capozzi A; Scambia G
    Gynecol Endocrinol; 2020 Jul; 36(7):567-568. PubMed ID: 32530328
    [No Abstract]   [Full Text] [Related]  

  • 18. MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.
    Leitman DC; Christians U
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1031-42. PubMed ID: 22616988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo dissection of the estrogen receptor alpha: uncoupling of its physiological effects and medical perspectives.
    Arnal JF; Gourdy P; Lenfant F
    Ann Endocrinol (Paris); 2013 May; 74(2):82-9. PubMed ID: 23566615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
    Stovall DW
    Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.